Best Medication for Comorbid Anxiety, Major Depression, OCD, Insomnia, and PTSD
Start with an SSRI—specifically sertraline or paroxetine—as these medications address the majority of your conditions simultaneously and have the strongest evidence base across multiple disorders.
Rationale for SSRI Selection
When treating this complex constellation of disorders, you need a single agent that provides broad-spectrum coverage. SSRIs are first-line for generalized anxiety disorder, major depressive disorder, OCD, and PTSD 1, 2. Among SSRIs, sertraline and paroxetine have FDA approval and strong guideline support for PTSD 3, while also being effective for the other conditions.
The 2023 VA/DoD PTSD guidelines specifically recommend paroxetine, sertraline, or venlafaxine (an SNRI) as first-line pharmacotherapy 3. Given that you have five concurrent conditions, sertraline or paroxetine offer the advantage of treating four of them with a single medication.
Addressing Insomnia
For insomnia secondary to these psychiatric conditions, do not add a benzodiazepine—the VA/DoD guidelines explicitly recommend against benzodiazepines in PTSD 3. Instead:
- First option: Add eszopiclone if insomnia persists after 4-6 weeks of SSRI treatment, as it has evidence for treating insomnia secondary to both major depression and generalized anxiety disorder 4
- Second option: Add low-dose trazodone (25-100mg at bedtime), which has support for insomnia secondary to depression 4
- For PTSD-specific nightmares: Consider adding prazosin 4, 5
Treatment Algorithm
Step 1: Initiate SSRI Monotherapy
- Start sertraline 50mg daily or paroxetine 20mg daily
- Titrate to therapeutic doses (sertraline 150-200mg, paroxetine 40-60mg for OCD)
- Allow 8-12 weeks for full response across all conditions
- OCD typically requires higher SSRI doses than depression or anxiety
Step 2: Address Residual Insomnia (if present after 4-6 weeks)
- Add eszopiclone 2-3mg at bedtime, OR
- Add trazodone 25-100mg at bedtime
- If nightmares are prominent: add prazosin 1mg at bedtime, titrate to 2-15mg
Step 3: If Inadequate Response After 12 Weeks
- Switch to venlafaxine XR 150-225mg daily (alternative first-line agent with broader coverage) 3, 1
- Venlafaxine (SNRI) has evidence for GAD, depression, PTSD, and anxiety disorders
Critical Pitfalls to Avoid
Do not use benzodiazepines despite their intuitive appeal for anxiety and insomnia—they are contraindicated in PTSD and worsen long-term outcomes 3. Similarly, avoid cannabis or cannabis-derived products, which the VA/DoD guidelines explicitly recommend against 3.
Do not undertreate OCD—it requires higher SSRI doses (often maximum FDA-approved doses) and longer trial durations (10-12 weeks minimum) than depression or anxiety disorders 1, 2.
Psychotherapy Integration
While you asked specifically about medication, the evidence strongly favors combining pharmacotherapy with trauma-focused psychotherapy for PTSD. The VA/DoD guidelines give their strongest recommendation to manualized psychotherapies over pharmacotherapy alone for PTSD, specifically prolonged exposure, cognitive processing therapy, or EMDR 3. For depression, the ACP guidelines show no difference between SSRIs and CBT monotherapy, but combination therapy may improve work functioning 6.
Why Not Other Options?
- Quetiapine: While effective for GAD 7, it lacks evidence for OCD and PTSD, and carries metabolic risks
- Pregabalin: Effective for GAD 1, 2, 7 but no evidence for OCD or PTSD
- Tricyclic antidepressants: Equally effective but poorly tolerated 2
- Duloxetine: Good for GAD and depression 7 but limited PTSD evidence
The SSRI approach provides the most parsimonious solution—one medication addressing four of five conditions, with targeted augmentation for insomnia only if needed after adequate SSRI trial.